Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.
Clinical trial NCT05918302 · RECRUITING
Trial details
- NCT number
- NCT05918302
- Sponsor
- Grupo Espanol de Tumores Neuroendocrinos
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-27
- Primary completion
- 2029-03-01
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.